GlassScriptPhysician profile
Micah L Hemani
NPI 1396941860
$3,168.94
in general payments reported to CMS, 2019-2025
30 companies · $1,468 in 2025
The $1,468 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $17.48 · 2023: $149 · 2024: $1,398 · 2025: $1,468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,815 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,815.20 |
| Education | $198.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $453.78 | 2024-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $295.24 | 2019-2025 | Veozah, Myrbetriq, Xtandi |
| Antares Pharma, INC. | $271.44 | 2024-2025 | Xyosted |
| Tolmar, INC. | $229.17 | 2024-2025 | Eligard, Jatenzo |
| Endo USA, INC. | $221.77 | 2024-2025 | Aveed, Xiaflex |
| Ferring Pharmaceuticals INC. | $186.85 | 2024-2025 | Adstiladrin |
| Histosonics, INC. | $148.89 | 2025 | |
| Merck Sharp & Dohme LLC | $140.30 | 2024-2025 | Keytruda, Lynparza, Keytruda Qlex |
| 180 Medical, INC. | $131.81 | 2019-2025 | Gentlecath, Cure Catheter |
| Urogen Pharma, INC. | $115.11 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $97.33 | 2019-2024 | Xiaflex, Aveed |
| Teleflex LLC | $91.47 | 2024-2025 | Barrigel, Urolift |
| Abbvie INC. | $69.27 | 2019-2023 | |
| Boston Scientific Corporation | $65.57 | 2019-2025 | Lithovue, Solyx Sis System |
| Pfizer INC. | $62.57 | 2024-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $62.00 | 2024 | |
| Bluewind Medical | $61.07 | 2024 | Revi |
| Progenics Pharmaceuticals, INC. | $55.93 | 2025 | |
| Verity Pharmaceuticals INC. | $52.13 | 2025 | Trelstar, Tlando |
| Medtronic, INC. | $48.14 | 2023-2024 | Interstim |
| Accord Healthcare, INC. | $47.19 | 2025 | |
| Coloplast Corp | $46.20 | 2019-2024 | |
| Agiliti Surgical, INC. | $34.15 | 2024 | Koelis Trinity Fusion Biopsy System, Sonablate Hifu |
| Novartis Pharmaceuticals Corporation | $32.54 | 2024 | |
| Procept Biorobotics Corporation | $32.24 | 2024 | Aquabeam System |
| Janssen Biotech, INC. | $28.36 | 2025 | Erleada |
| Novo Nordisk INC | $24.85 | 2024 | Rivfloza |
| Bioprotect Medical, INC. | $23.55 | 2025 | Bioprotect Balloon Implant System |
| Caris Mpi, INC. | $22.50 | 2025 | Mi Cancer Seek |
| Calyxo, INC. | $17.52 | 2025 | Cvac Aspiration System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micah Hemani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.